Clinical Trial Results:
            A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of SCH 900340 5% Solution Compared with Vehicle Administered Topically in the Treatment of Distal Subungual Onychomycosis of the Toenail.
NOTE: "The product to be used in the clinical trial is a "Topical Solution".  Of the choices provided in Section D.3.4 Pharmaceutical Form; per the standard list, "Medicated Nail Lacquer" was selected at this time."
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2007-004331-27 | 
    Trial protocol  | 
        DE IS BE SE ES GB BG | 
    Global completion date  | 
        
                                    23 Dec 2008
                             
         | 
    
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
| 
                 Results information 
         | 
        |
    Results version number  | 
        v1(current) | 
    This version publication date  | 
        
                                    08 Jun 2019
                             
         | 
    
    First version publication date  | 
        
                                    08 Jun 2019
                             
         | 
    
    Other versions  | 
        |
    Summary report(s)  | 
                                Cancelled/ Withdrawn Memo | 
    
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.